Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2024

Apr 26, 2024

BUY
$233.45 - $247.73 $606,970 - $644,098
2,600 New
2,600 $643,000
Q3 2022

Nov 14, 2022

BUY
$51.03 - $264.23 $7.58 Million - $39.2 Million
148,500 Added 9900.0%
150,000 $33.4 Million
Q2 2022

Aug 15, 2022

SELL
$234.74 - $275.42 $34.9 Million - $40.9 Million
-148,500 Reduced 99.0%
1,500 $370,000
Q1 2022

May 13, 2022

BUY
$243.64 - $270.48 $36.5 Million - $40.6 Million
150,000 New
150,000 $38.9 Million

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $65.4B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Caas Capital Management LP Portfolio

Follow Caas Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caas Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Caas Capital Management LP with notifications on news.